Patient reported outcomes in thoracic trauma-lesson learned from thoracic oncology.

Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-576/coif). AB serves as an unpaid editorial board member of Journal of Thoracic Disease from April 2022 to March 2024. CP serves as an unpaid editorial board member of Journal of Thoracic Disease from October 2022 to September 2024. AB reports consulting Fees and payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing or educational events with Astra Zeneca, MSD, BMS and Ethicon and is a member of the Board of Directors of ESTS and STS. CP reports consulting fees for Astra Zeneca and Medela. The other authors have no conflicts of interest to declare.